Sampre Nutritions received in-principal approval from the Bombay Stock Exchange on August 28, 2026, for a preferential issue of equity shares. The transaction involves the conversion of unsecured loans held by promoters into equity, strengthening the company’s capital structure without immediate cash outflow.

The exchange approved the issuance of 17,70,710 equity shares with a face value of ₹5 each. The shares are priced at not less than ₹42 per share, corresponding to the conversion of unsecured loans aggregating to ₹7,43,69,820. The allotment is restricted to the promoter and promoter group category.

Transaction Details

The preferential issue serves as a debt-to-equity swap, reducing the company’s liability while increasing promoter holding. Key parameters of the approved transaction include:

Regulatory Compliance

BSE Limited advised Sampre Nutritions to ensure strict compliance with the Companies Act, 2013, SEBI (ICDR) Regulations, 2018, and SEBI (LODR) Regulations, 2015. The exchange emphasized the need for robust internal controls to monitor trades by allottees before the allotment date.

Specific compliance requirements outlined by the exchange include:

• Obtaining undertakings from allottees confirming no intra-day trading or sale of scrip until the allotment date.
• Verifying these undertakings to ensure adherence to Regulation 167(6) of SEBI ICDR regulations.
• Submitting a listing application within twenty days from the date of allotment, as per Schedule XIX – Para (2) of ICDR Regulations.

Failure to comply with listing timelines may attract fines under SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023. The exchange reserved the right to withdraw in-principal approval if submitted information is found incomplete or misleading.

Sampre Nutritions Limited has filed its annual report for the financial year 2025-26 and issued the notice convening its Thirty-Fifth Annual General Meeting (AGM). The meeting is scheduled to be held on Friday, September 4, 2026, at 11:00 am through Video Conferencing or Other Audio-Visual Means, in accordance with applicable circulars from the Ministry of Corporate Affairs and SEBI.

The company communicated a corrigendum to members via email to rectify certain typographical errors in the dates relating to the appointment of the Scrutinizer and the publication of the AGM results. Sampre Nutritions stated that these errors were purely typographical and did not affect the substance of the Notice of AGM, the resolutions proposed, or any material information contained in the Annual Report.

The corrected Annual Report has been dispatched to members and uploaded on the company’s website. Members are requested to refer to and rely upon the corrected document for FY26.

The filing was made pursuant to Regulations 30 and 34(1) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Brahma Gurbani, Managing Director, signed the communication dated August 14, 2026.